3J = 3.0 Hz, 0.5H, NCHCH2OMs), 3.56 (dd, J = 12.6, J =
2.8 Hz, 1H, NCHCH2OMs), 3.58–3.90 (m, 0.5H, NCHCH2OMs),
3.92 (s, 3H, OCH3), 3.93 (s, 1.5H, OCH3), 3.95–3.99 (m, 0.5H,
NCHCH2OMs), 4.85–4.92 (m, 1.5H, NCHCH2OMs), 5.55 (brs,
1H, OH), 5.83 (brs, 0.5H, OH), 7.34–7.36 (m, 1.5H, HC CCHO),
9.41 (s, 1H, CHO), 9.43 (s, 0.5H, CHO). 13C NMR (CDCl3,
50 MHz) d 21.4 (0.5C, NCH2CH2CH2), 21.5 (1C, NCH2CH2CH2),
29.4 (1C, NCH2CH2CH2), 30.9 (0.5C, NCH2CH2CH2), 38.5 (1C,
SCH3), 38.6 (0.5C, SCH3), 50.5 (1C, NCH2CH2CH2), 50.9 (0.5C,
NCH2CH2CH2), 53.4 (0.5C, OCH3), 54.5 (1C, OCH3), 54.6
(0.5C, NCHCH2OMs), 54.9 (1C, NCHCH2OMs), 73.7 (0.5C,
NCHCH2OMs), 74.2 (1C, NCHCH2OMs), 74.9 (q, 2JC-F = 31 Hz,
enamine reactivity, 2a (195.3 mg, 0.990 mmol, 1 eq) and methyl
trifluoropyruvate (320 mL, 3.023 mmol, 3.0 eq) afforded 292.0
mg of 4a as white crystals (84%) after silica gel flash chro-
matography (petroleum ether : EtOAc 80 :◦20). Rf : 0.19 (petroleum
ether : EtOAc 80 : 20). Mp: 138.1–139.4 C. IR (KBr, n, cm-1):
3433, 3112, 2963, 2894, 2858, 1737, 1681, 1464, 1435, 1372, 1283,
2
3
1
1251, 1208, 1161, 1121, 997, 920, 892, 650. H NMR (CDCl3,
300 MHz) d 2.87–2.94 (m, 2H, NCH2), 3.07–3.14 (m, 2H, NCH2),
3.75–3.88 (m, 4H, OCH2), 3.88 (s, 3H, CO2CH3), 7.17 (brs, 1H,
OH), 7.79 (d, 4J = 1.1 Hz, 1H, CH CCHO), 9.78 (s, 1H, CHO).
13C NMR (CDCl3, 75 MHz) d 54.0 (CO2CH3), 55.8 (2C, NCH2),
66.34 (2C, OCH2), 77.2 (q, 2JC-F = 30 Hz, CCF3), 123.0 (q, 1JC-F
=
2
1C, CCF3), 75.0 (q, JC-F = 31 Hz, 0.5C, CCF3), 105.6 (1C,
285 Hz, CF3), 126.1 (NC CCCF3OH), 135.3 (CH CCHO),
137.8 (NC CCCF3OH), 164.9 (CH CCHO), 168.2 (CO2CH3),
182.7 (CHO). 19F NMR (CDCl3, 188 MHz) d -76.7 (s, 3F).
MS (ESI+, CH3CN) m/z (rel int): 217.1 (65), 262.1 (20), 318.1
(30), 376.0 (50, M + Na+), 418.1 (30), 474.1 (100), 729.1 (20,
2M + Na+). HRMS (ESI+, CH3CN) m/z: calcd for (M + Na+)
C13H14NO5F3SNa 376.0442; found 376.0434.
1
C
CN), 106.6 (0.5C, C CN), 122.9 (q, JC-F = 285 Hz, 1.5C,
CF3), 123.5 (0.5C, HC CCHO), 123.8 (1C, HC CCHO), 146.3
(1C, C CN), 146.7 (0.5C, C CN), 159.0 (0.5C, HC CCHO),
159.4 (1C, HC CCHO), 168.0 (0.5C, CO2CH3), 168.3 (1C,
CO2CH3), 176.1 (1C, CHO), 176.3 (0.5C, CHO). 19F NMR
(CDCl3, 188 MHz) d -76.8 (s, 3F), -76.9 (s, 1.5F). MS (ESI+,
CH3CN) m/z (rel int): 242.3 (30), 452.1 (100, M + Na+), 881.1
(100, 2M + Na+). HRMS (ESI+, CH3CN) m/z: calcd for (M +
Na+) C15H18NO8SF3Na 452.0603; found 452.0603.
Methyl 3,3,3-trifluoro-2-(5-formyl-2-(piperidin-1-yl)thiophen-3-
yl)-2-hydroxypropanoate (4b). Following the general procedure
for enamine reactivity, 2b (51.5 mg, 0.264 mmol, 1 eq) and
methyl trifluoropyruvate (32 mL, 0.312 mmol, 1.2 eq) afforded
61.1 mg of 4b as white solid (66%) after silica gel flash chro-
matography (petroleum ether : EtOAc 85 : 15). Rf : 0.41 (petroleum
ether : EtOAc 80 : 20); 0.81 (petroleum ether : EtOAc 60 : 40). Mp:
112.4–113.2 ◦C. IR (KBr, n, cm-1): 3244, 2943, 2854, 2815, 1758,
1659, 1443, 1416, 1374, 1315, 1279, 1245, 1214, 1179, 1152, 1124,
1042, 1028, 1008, 996, 860, 786, 724, 664, 648. 1H NMR (CDCl3,
300 MHz) d 1.58–1.64 (m, 2H, NCH2CH2CH2), 1.72–1.79 (m, 4H,
NCH2CH2), 2.86–2.93 (m, 2H, NCH2), 2.96–3.04 (m, 2H, NCH2),
Methyl 2-(2-((S)-2-((tert-butoxycarbonyloxy)methyl) pyrrolidin-
1-yl)-5-formylfuran-3-yl)-3,3,3-trifluoro-2-hydroxy
propanoate
(3ha). To a solution of 1h (245.0 mg, 0.829 mmol, 1 eq) in
CH2Cl2 (10 mL) was added methyl trifluoropyruvate a (270 mL,
2.551 mmol, 3.0 eq) at rt. The solution was stirred at rt for 16
h, then the solvent was evaporated and the residue was purified
by silica gel flash chromatography (petroleum ether : EtOAc 1 : 1)
to afford 229.4 mg of 3ha as an yellow oil (62%, 2 diastereomers
in the ratio 5 : 1). Rf : 0.69 (petroleum ether : EtOAc 1 : 1). IR (in
CCl4, n, cm-1): 3411–3233, 2980, 2896, 1747, 1660, 1651, 1645,
1583, 1548, 1538, 1455, 1395, 1370, 1281, 1255, 1155, 1103, 1026,
4
3.88 (s, 3H, CO2CH3), 7.79 (d, J = 1.4 Hz, 1H, CH CCHO),
8.60 (brs, 1H, OH), 9.80 (s, 1H, CHO). 13C NMR (CDCl3,
75 MHz) d 23.0 (1C, NCH2CH2CH2), 25.6 (2C, NCH2CH2CH2),
53.8 (CO2CH3), 57.7 (2C, NCH2), 77.7 (q, 2JC-F = 30 Hz, CCF3),
1
998, 957, 911, 861, 796, 786, 733, 679, 648. H NMR (CDCl3,
300 MHz) d 1.39 (s, 3H, OBoc), 1.40 (s, 9H, OBoc), 1.76–1.97
(m, 3.8H, NCH2C2H4), 1.99–2.11 (m, 1.3H, NCH2C2H4),
3.41–3.47 (m, 1H, NCH2), 3.49–3.57 (m, 1.2H, NCH2), 3.86
(s, 0.8H, OCH3), 3.87 (s, 3H, OCH3), 4.05 (d, 3J = 4.6 Hz,
2.5H, NCHCH2OBoc), 4.33–4.42 (m, 1.3H, NCHCH2OBoc),
4.80–5.06 (br, 1H, OH), 5.05–5.20 (br, 0.2H, OH), 7.30–7.32 (m,
1
123.2 (q, JC-F = 283 Hz, CF3), 125.6 (NC CCCF3OH), 135.2
(CH CCHO), 138.0 (NC CCCF3OH), 165.9 (CH CCHO),
168.0 (CO2CH3), 182.7 (CHO). MS (ESI+, CH3CN) m/z (rel int):
352.1 (15, M + H+), 374.1 (100, M + Na+), 725.1 (70, 2M + Na+).
HRMS (ESI+, CH3CN) m/z: calcd for (M + H+) C14H17NO4F3S
352.0830; found 352.0816.
1.2H, HC CCHO), 9.15 (s, 1H, CHO), 9.16 (s, 0.2H, CHO). 13
C
NMR (CDCl3, 75 MHz) d 24.2 (0.2C, NCH2CH2CH2), 24.9 (1C,
NCH2CH2CH2), 27.5 (OCO2CH3), 27.6 (3C, NCH2CH2CH2),
51.7 (0.2C, NCH2CH2CH2), 52.9 (1C, NCH2CH2CH2), 54.3
(0.2C, OCH3), 54.6 (1C, OCH3), 59.0 (1C, NCH), 59.2 (0.2C,
(2S)-1-(3-(1-Methoxycarbonyl)-2,2,2-trifluoro-1-hydroxyethyl -
5-formylthiophen-2-yl)pyrrolidine-2-carboxylic acid (4d). To a
solution of 2d (185.6 mg, 0.824 mmol, 1 eq) in CH2Cl2 (6 mL) was
added methyl trifluoropyruvate (135 mL, 1.275 mmol, 1.5 eq) at rt.
After 42 h, the solvent was evaporated and the residue was purified
by silica gel flash chromatography (petroleum ether : EtOAc 1 : 1 to
0 : 1) to afford 312.5 mg of 4d as an yellow oil (99%, 2 diastereomers
in the ratio 2 : 1). Rf : 0.15 (petroleum ether : EtOAc 1 : 1); 0.04–0.25
(CH2Cl2 : MeOH 95 : 5). IR (KBr, n, cm-1): 3450–2400, 1755, 1747,
1651, 1633, 1470, 1462, 1454, 1416, 1281, 1241, 1159, 1122, 1094,
2
NCH), 66.8 (1C, OCH2), 75.1 (q, JC-F = 30 Hz, 1C, CCF3),
2
75.4 (q, JC-F = 30 Hz, 0.2C, CCF3), 82.2 (1C, C), 82.3 (0.2C,
1
C), 99.2 (1C, C), 99.7 (0.2C, C), 122.9 (q, JC-F = 286 Hz, 1C,
CF3), 126.9 (0.2C, HC CCHO), 127.3 (1C, HC CCHO), 143.5
(1C, C), 143.9 (0.2C, C), 153.2 (0.2C, C), 153.3 (1C, C), 158.1
(0.2C, OCO2), 159.0 (1C, OCO2), 168.8 (0.2C, CO2), 169.5 (1C,
CO2), 173.8 (1C, CHO), 173.9 (0.2C, CHO). 19F NMR (CDCl3,
188 MHz) d -76.8 (s, 3F), -77.4 (s, 0.6F). MS (ESI+, CH3CN)
m/z (rel int): 474.1 (20, M + Na+), 635.2 (10), 925.2 (100, 2M +
Na+), 926.2 (40). HRMS (ESI+, CH3CN) m/z: calcd for (M +
Na+) C19H24NO8F3Na 474.1352; found 474.1351.
1
1027, 996, 937, 730, 675. H NMR (CDCl3, 300 MHz) d 1.93–
2.20 (m, 4.5H, NCH2C2H4), 2.35–2.47 (m, 1.5H, NCH2C2H4),
3.02–3.10 (m, 0.5H, NCH2), 3.18–3.25 (m, 1H, NCH2), 3.58–3.71
(m, 1.5H, NCH2), 3.81 (s, 3H, CH3), 3.84 (s, 1.5H, CH3), 3.88 (s,
3
1.5H, OH), 4.22 (dd, J = 8.6 and 5.0 Hz, 0.5H, NCHCOOH),
Methyl 3,3,3-trifluoro-2-(5-formyl-2-morpholinothiophen-3-yl)-
2-hydroxypropanoate (4a). Following the general procedure for
4.29 (dd, 3J = 8.4 and 5.3 Hz, 1H, NCHCOOH), 6.77–7.60
4
(brs, COOH), 7.73 (d, J = 1.5 Hz, 1H, HC CCHO), 7.76 (d,
This journal is
The Royal Society of Chemistry 2011
Org. Biomol. Chem., 2011, 9, 6055–6065 | 6063
©